Whom do we partner with?
We partner with academia, biotech and pharma to strengthen our portfolio and pipeline. We’re interested in global and regional partnerships at all development stages, from early discovery to marketed products
Are there pharmaceutical assets or delivery technologies where we can collaborate?
Our agile and capable R&D organization is ready to advance your assets towards commercial success
We partner with VC and PE firms whose portfolio of companies offer innovative compounds
We partner with Ph.D's, post-doctorates and scientists on the verge of groundbreaking drug discovery.